The Rising Remote Monitoring And Telehealth Adoption Are Driving The Market Due To Demand For Convenient Diabetes Management Continues To Impact The Growth Of The Real-Time Blood Glucose CGM Patch Market
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Real-Time Blood Glucose CGM Patch Market During 2026–2030?
The real-time blood glucose cgm patch market has experienced rapid growth in recent years. This market is forecast to expand from $7.05 billion in 2025 to $7.77 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.1%. The expansion observed in the historic period is largely attributable to factors such as rising diabetes prevalence, the limitations inherent in finger-prick testing, the increasing adoption of wearable medical devices, a growing demand for patient self-monitoring, and ongoing healthcare digitalization.
The real-time blood glucose CGM patch market size is projected to witness significant expansion in the coming years. This market is expected to reach $11.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. The anticipated growth during the forecast period is fueled by elements such as AI-based glucose prediction, the incorporation of telehealth services, proactive diabetes management, the broadening of remote patient monitoring, and supportive reimbursement policies. Prominent trends for the forecast period include continuous glucose monitoring wearables, the development of needle-free glucose tracking solutions, real-time glucose notifications, long-lasting wearable patches, and enhanced sensor precision.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29165&type=smp
Which Strategic Drivers Are Supporting The Real-Time Blood Glucose CGM Patch Market Development?
The real-time blood glucose CGM patch market is projected to grow as a result of the increasing adoption of remote monitoring and telehealth. Remote monitoring refers to the application of digital technologies to collect and transmit a patient’s health information, such as blood glucose levels, heart rate, or blood pressure, from outside conventional clinical settings to medical professionals for ongoing assessment and management. Telehealth adoption, on the other hand, involves the expanding use of virtual healthcare services, including video consultations, remote follow-ups, and digital communication channels between patients and providers. The rise in remote monitoring and telehealth adoption is driven by a surging demand for accessible and convenient healthcare services, especially for managing long-term conditions like diabetes. The real-time blood glucose CGM patch supports this trend by enabling continuous, real-time data sharing with healthcare providers, facilitating timely interventions and virtual diabetes management. For instance, in February 2025, according to the American Hospital Association (AHA), a US-based national organization, the United States is predicted to experience a shortage of up to 86,000 physicians by 2036, which highlights the crucial role of telehealth in addressing this expanding healthcare gap. Therefore, the increasing adoption of remote monitoring and telehealth is fueling the expansion of the real-time blood glucose CGM patch market.
How Is The Real-Time Blood Glucose CGM Patch Market Structured Across Different Market Segments?
The real-time blood glucose cgm patch market covered in this report is segmented –
1) By Product Type: Wearable Continuous Glucose Monitoring Patch, Implantable Continuous Glucose Monitoring Patch
2) By Technology: Enzymatic, Non-Enzymatic
3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications
4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users
Subsegments:
1) By Wearable Continuous Glucose Monitoring Patch: Arm Patches, Abdominal Patches
2) By Implantable Continuous Glucose Monitoring Patch: Short-Term Implantable Patches, Long-Term Implantable Patches
What Trends Are Affecting The Real-Time Blood Glucose CGM Patch Market Dynamics?
Leading firms within the real-time blood glucose continuous glucose monitoring (CGM) patch market are concentrating their efforts on creating novel products, specifically water-resistant sensors, with the aim of improving user ease and the dependability of ongoing monitoring. Such a sensor is an apparatus engineered to operate precisely and without interruption, even upon contact with water or perspiration, thereby safeguarding its internal constituents from harm. An example of this is Dexcom Inc., a US-based medical device company, which introduced the Dexcom ONE+, a real-time continuous glucose monitoring (CGM) system, in Spain, Belgium, and Poland during February 2024. This system presents a more compact, precise, and intuitive CGM solution, delivering continuous real-time glucose data 24/7, accompanied by customizable alerts, notably a distinctive delay-first high feature designed to mitigate alarm fatigue. Furthermore, it integrates an all-in-one water-resistant sensor adaptable for various wear positions, boasts a quick 30-minute warm-up, provides a 10-day sensor lifespan complemented by a 12-hour grace period for sensor replacements, and ensures effortless connectivity with smartphones and receivers, thereby facilitating extensive diabetes management.
Which Companies Are Engaged In The Real-Time Blood Glucose CGM Patch Market Environment?
Major companies operating in the real-time blood glucose cgm patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Zhejiang POCTech Co. Ltd., MicroTech Medical Inc., Biolinq Inc., Metronom Health Inc., Afon Technology Ltd., Nemaura Medical Inc., Ultrahuman Healthcare Pvt. Ltd., PKvitality SAS, EOFlow Co. Ltd., i-SENS Inc., SiBio Technology Co. Ltd., Sinocare Inc., GlucoTrack Inc., Know Labs Inc., LifePlus Inc.
Access The Complete Real-Time Blood Glucose CGM Patch Market Report:
What Is The Largest Regional Market In The Real-Time Blood Glucose CGM Patch Market?
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose cgm patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Real-Time Blood Glucose CGM Patch Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Real-Time Blood Glucose CGM Patch Market 2026, By The Business Research Company
Blood Glucose Meters Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
Blood Glucose Monitoring Systems Market Report 2026
Continuous Glucose Monitoring Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
